Susan Roustaee, Mojtaba Sani, Maryam Mehranpour, Pourya Raee, Meysam Hassani Moghaddam, Reza Bahar, Seyedeh Naghmeh Nourirad, Mohammad-Jasim Golzarian, Amirreza Beirami, Hosein Jafary, Mohammad Amin Aalipour, Mohammad Taghizadeh, Mohammad-Amin Abdollahifar, Kimia Vakili, Mobina Fathi, Mohammad Hossain Heidari, Hojjat-Allah Abbaszadeh, Abbas Aliaghaei, Hamid Nazarian
Concerns have been raised about potentially irreversible brain damage and damage to the neuroendocrine system during development when treating attention-deficit/hyperactivity disorder with lisdexamfetamine (LDX), a norepinephrine dopamine reuptake inhibitor. This study aims to elucidate the potential adverse effects of LDX on the male reproductive system due to its widespread use and potential for abuse. In this study, adult male rats were randomized into control and LDX groups. Thirty milligrams per kilogram LDX was administered orally for 3 weeks...
January 16, 2024: Reproductive Sciences